DE69120107D1 - Grundlage oder Hilfsstoff zur externen Anwendung sowie diese bzw. diesen enthaltende Mittel zur externen Anwendung an einem menschlichen Wesen oder Tier - Google Patents

Grundlage oder Hilfsstoff zur externen Anwendung sowie diese bzw. diesen enthaltende Mittel zur externen Anwendung an einem menschlichen Wesen oder Tier

Info

Publication number
DE69120107D1
DE69120107D1 DE69120107T DE69120107T DE69120107D1 DE 69120107 D1 DE69120107 D1 DE 69120107D1 DE 69120107 T DE69120107 T DE 69120107T DE 69120107 T DE69120107 T DE 69120107T DE 69120107 D1 DE69120107 D1 DE 69120107D1
Authority
DE
Germany
Prior art keywords
external use
animal
human
basis
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69120107T
Other languages
English (en)
Other versions
DE69120107T2 (de
Inventor
Yasuyuki Sakai
Noriyuki Suzuki
Tetsuo Kudo
Kuniomi Marumo
Toshiyuki Aizawa
Kunio Imamura
Shuichi Sugita
Kazuo C O Showa De Kanabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Resonac Holdings Corp
Original Assignee
Showa Denko KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Showa Denko KK filed Critical Showa Denko KK
Publication of DE69120107D1 publication Critical patent/DE69120107D1/de
Application granted granted Critical
Publication of DE69120107T2 publication Critical patent/DE69120107T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Materials For Medical Uses (AREA)
DE69120107T 1990-03-12 1991-02-13 Grundlage oder Hilfsstoff zur externen Anwendung sowie diese bzw. diesen enthaltende Mittel zur externen Anwendung an einem menschlichen Wesen oder Tier Expired - Lifetime DE69120107T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP6074190 1990-03-12
JP6223390 1990-03-12
JP6223290 1990-03-12
JP6223490 1990-03-12

Publications (2)

Publication Number Publication Date
DE69120107D1 true DE69120107D1 (de) 1996-07-18
DE69120107T2 DE69120107T2 (de) 1997-02-27

Family

ID=27463950

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120107T Expired - Lifetime DE69120107T2 (de) 1990-03-12 1991-02-13 Grundlage oder Hilfsstoff zur externen Anwendung sowie diese bzw. diesen enthaltende Mittel zur externen Anwendung an einem menschlichen Wesen oder Tier

Country Status (4)

Country Link
US (3) US5254338A (de)
EP (1) EP0446636B1 (de)
JP (1) JP3046346B2 (de)
DE (1) DE69120107T2 (de)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512277A (en) 1991-05-15 1996-04-30 Kao Corporation Keratotic plug remover
JP2920451B2 (ja) * 1993-03-29 1999-07-19 エスエス製薬株式会社 消炎鎮痛貼付剤
US5960795A (en) 1993-07-16 1999-10-05 Tecnol Medical Products, Inc. Wound covering device
JP3106820B2 (ja) * 1993-12-08 2000-11-06 アールティーエー・アソシエーツ有限会社 畜肉、魚肉およびこれらの加工品の鮮度保持剤並びに生産性改善剤
US6055982A (en) * 1993-12-15 2000-05-02 Kimberly-Clark Worldwide, Inc. Disposable face mask with enhanced fluid barrier
CA2177683C (en) * 1993-12-23 1999-12-28 George Endel Deckner Tissue moisturizing and antimicrobial compositions
CA2177682C (en) * 1993-12-23 1999-12-28 Sekhar Mitra Antimicrobial wipe compositions
US6228383B1 (en) * 1994-03-03 2001-05-08 Gs Development Ab Use of fatty acid esters as bioadhesive substances
US5833622A (en) * 1994-04-04 1998-11-10 Graphic Controls Corporation Non-invasive fetal probe having improved mechanical and electrical properties
US5474065A (en) * 1994-04-04 1995-12-12 Graphic Controls Corporation Non-invasive fetal probe
DE4414254A1 (de) * 1994-04-23 1995-10-26 Basf Ag Iodophor aus Poly-N-vinyllactam und Dextrin
EP0774954B1 (de) * 1994-07-05 1999-08-04 LTS LOHMANN Therapie-Systeme GmbH Hydrogel für die applikation von therapeutischen und/oder kosmetischen wirkstoffen an die haut
US5892115A (en) * 1996-01-16 1999-04-06 Showa Denko Kabushiki Kaisha Highly polymerizable N-vinylcarboxylic acid amide and production process thereof
US5560910A (en) * 1994-08-26 1996-10-01 Crandall; Wilson T. Topical anti-inflammatory composition and method
US5562899A (en) * 1995-02-28 1996-10-08 Gerber; Allen Medical prevention of lacerations to the vagina and perineum
JPH08243377A (ja) * 1995-03-09 1996-09-24 Showa Denko Kk アルコール含有ゲル体
AU6482596A (en) 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
DE19540853A1 (de) * 1995-11-03 1997-05-07 Henkel Kgaa Haarbehandlungsmittel
GB2308123A (en) * 1995-12-15 1997-06-18 Mitsubishi Chem Corp Process for the preparation of an aqueous solution or dispersion containing cationic polymer
IT1283102B1 (it) * 1996-06-06 1998-04-07 Permatec Nv Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
DE19649237A1 (de) * 1996-11-28 1998-06-04 Bluecher Gmbh Material mit antiseptischen Eigenschaften
US6599999B1 (en) * 1997-02-04 2003-07-29 National Starch And Chemical Investment Holding Corporation Hair care compositions containing polymeric N-vinyl acetamide and methods of treating hair
US5935596A (en) * 1997-03-20 1999-08-10 Chesebrough-Pond's Usa Co. Delivery of skin benefit agents via adhesive strips
US5968537A (en) * 1997-03-20 1999-10-19 Chesebrough-Pond's Usa Co. Cosmetic product for removal of keratotic plugs from skin pores
US5993838A (en) * 1997-03-20 1999-11-30 Chesebrough-Pond's Usa Co., Cosmetic product for removal of keratotic plugs from skin pores
US6174536B1 (en) 1997-08-01 2001-01-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic product for removal of keratotic plugs from skin pores
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
FR2768624B1 (fr) * 1997-09-25 1999-11-12 Oreal Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue
KR19990026792A (ko) * 1997-09-26 1999-04-15 김윤 디클로페낙 디에틸암모늄염을 함유한 매트릭스형 패취제제
US6106857A (en) * 1998-03-10 2000-08-22 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Fragranced cosmetic product for removal of keratotic plugs from skin pores
AU6853198A (en) * 1998-04-17 1999-11-08 Lead Chemical Co., Ltd. Estradiol-containing percutaneous absorption preparations
US6106818A (en) * 1998-04-27 2000-08-22 Revlon Consumer Products Corporation Method for removing dead surface cells, dirt, oil, and blackheads from the skin and related compositions and articles
JP4064574B2 (ja) * 1998-07-29 2008-03-19 株式会社資生堂 抗糖尿病用皮膚外用剤
US6241998B1 (en) 1999-02-02 2001-06-05 Acutek International Dermatological patch
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
WO2000064434A1 (fr) * 1999-04-26 2000-11-02 Lead Chemical Co., Ltd. Preparations percutanees contenant de l'oxybutynine
WO2000069397A1 (fr) * 1999-05-12 2000-11-23 Kao Corporation Agent enlevant la corne produite par la glande sebacee
US6946118B1 (en) * 1999-09-14 2005-09-20 Orapharma, Inc. Formulations for treating or preventing mucositis
JP4764588B2 (ja) * 2000-02-22 2011-09-07 カラー アクセス，インコーポレイティド ゲル化された水性化粧品組成物
US7223418B2 (en) * 2000-03-07 2007-05-29 Tiejin Limited Stretchable patch
DE10035891A1 (de) * 2000-07-24 2002-02-14 Lohmann Therapie Syst Lts Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
DE10103860B4 (de) * 2001-01-30 2004-12-23 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung
US20030026829A1 (en) * 2001-03-16 2003-02-06 Venkatraman Subramanian S. Transdermal administration of fentanyl and analogs thereof
US20050208117A1 (en) * 2001-03-16 2005-09-22 Venkatraman Subramanian S Transdermal administration of fentanyl and analogs thereof
US6951642B2 (en) 2001-09-28 2005-10-04 3M Innovative Properties Company Water-in-oil emulsions with anionic groups, compositions, and methods
US7030203B2 (en) 2001-09-28 2006-04-18 3M Innovative Properties Company Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
JP4068402B2 (ja) * 2001-10-26 2008-03-26 株式会社トッパンＴｄｋレーベル スクラッチカード
USRE45936E1 (en) 2002-01-25 2016-03-22 Hisamitsu Pharmaceutical Co., Inc. Pressure-sensitive adhesive and patch employing the same
JP4194277B2 (ja) * 2002-01-25 2008-12-10 久光製薬株式会社 架橋ポリマーを主成分とする粘着性成形体の製造方法
JP4167834B2 (ja) * 2002-01-25 2008-10-22 久光製薬株式会社 粘着剤およびこれを用いてなる貼付製剤
DE10211140A1 (de) * 2002-03-14 2003-09-25 Clariant Gmbh Stabile Dispersionskonzentrate
PT1496951E (pt) * 2002-04-24 2006-10-31 Insense Ltd Pensos para feridas que compreendem uma enzima oxidorreductase em condicao hidratada
KR20050045946A (ko) 2002-06-25 2005-05-17 애크럭스 디디에스 피티와이 리미티드 비정질 약학적 조성물을 이용한 경피전달속도의 제어
JP2004034631A (ja) * 2002-07-08 2004-02-05 Nitto Denko Corp 光学フィルム用表面保護フィルム
AU2003290613A1 (en) * 2002-11-05 2004-06-07 New River Pharmaceuticals Inc. Controlled absorption of mixed thyroyd hormone formulations
WO2004078165A1 (ja) * 2003-03-07 2004-09-16 Toagosei Co., Ltd. 貼付剤用基剤及びそれを用いた貼付剤
US7052715B2 (en) * 2003-04-11 2006-05-30 All Natural Fmg, Inc. Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof
EP1631667A1 (de) * 2003-06-09 2006-03-08 Insense Limited Verfahren zur stabilizierung von enzymen während diese sterilisierender bestrahlung ausgesetz sind
US20050181026A1 (en) * 2003-06-09 2005-08-18 Insense Limited Skin dressings
GB0313217D0 (en) 2003-06-09 2003-07-16 Insense Ltd Improvements in or relating to skin dressings
KR100506543B1 (ko) * 2003-08-14 2005-08-05 주식회사 제닉 온도 감응성 상태변화 하이드로겔 조성물 및 그 제조방법
DE10343413A1 (de) * 2003-09-19 2005-04-14 Universität Hamburg Vernetzte, langzeitstabile Carboxymethylstärke als Absorptionsmittel für Wasser, deren Verwendung sowie Verfahren zu deren Herstellung
ES2426990T3 (es) * 2003-10-24 2013-10-28 Adhesives Research, Inc. Películas desintegrables para dispositivos de diagnóstico
US9248146B2 (en) * 2003-10-24 2016-02-02 Adhesives Research, Inc. Dissolvable adhesive films for delivery of pharmaceutical or cosmetic agents
DE10351004A1 (de) * 2003-10-30 2005-05-25 Basf Ag Nanopartikuläre Wirkstoffformulierungen
JP2007519459A (ja) * 2004-01-30 2007-07-19 インセンス・リミテッド 水和性ヒドロゲル及び酵素を含む傷のドレッシング
PL1851255T3 (pl) * 2004-10-28 2015-12-31 Bayer Healthcare Llc Kompozycja hydrożelowa
US20060094944A1 (en) 2004-10-28 2006-05-04 Sontra Medical Corporation System and method for analyte sampling and analysis with error correction
PE20060796A1 (es) 2004-11-25 2006-09-29 Basf Ag Procedimiento para intensificar la eficiencia de etaboxam
GB0505035D0 (en) * 2005-03-11 2005-04-20 Insense Ltd Improvements relating to skin dressings
JP5243792B2 (ja) * 2005-06-01 2013-07-24 ニプロパッチ株式会社 貼付剤
ES2607454T3 (es) * 2005-06-03 2017-03-31 Acrux Dds Pty Ltd Método y composición para el suministro transdérmico de testosterona
CA2548864C (en) * 2005-06-06 2012-12-11 Nitto Denko Corporation Percutaneous absorption-type pharmaceutical preparation
DE602006003813D1 (de) * 2005-06-06 2009-01-08 Fujimoto Co Ltd Pharmazeutische Zusammensetzung zur perkutane Absorption unter Verwendung von einem Metalchlorid, vorzugsweise Natriumchlorid, zur Vorbeugung von Kohäsionsschwäche
JP2009540032A (ja) * 2006-06-07 2009-11-19 ビーエーエスエフ ソシエタス・ヨーロピア 酢酸ビニル−スルホナート共重合体の、水への溶解度が低い化合物のための可溶化剤としての使用
GB0614278D0 (en) * 2006-07-19 2006-08-30 Insense Ltd Hydrogen peroxide delivery system
US8036632B1 (en) * 2007-02-02 2011-10-11 Resource Consortium Limited Access of information using a situational network
AU2007343579B2 (en) 2007-01-11 2011-11-17 Acrux Dds Pty Ltd Spreading implement
US7726262B2 (en) * 2007-02-08 2010-06-01 Discoveries 180, Inc. Device and system for preventing animal wound licking
MX2009013810A (es) * 2007-07-06 2010-01-27 Basf Se Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos.
EP2207507B1 (de) * 2007-10-15 2018-11-21 Alza Corporation Einmal tägliche transdermale ersatz-verabreichung von fentanyl
ITMI20081552A1 (it) * 2008-08-29 2010-02-28 Biofarmitalia Spa Composizione migliorata per la trasmissione topica di principi attivi nel corpo umano od animale
ATE551389T1 (de) * 2009-08-07 2012-04-15 Ticona Llc Polyacetalzusammensetzung mit geringer formaldeyd-emission
US8999300B2 (en) 2009-10-26 2015-04-07 Nissan Chemical Industries Ltd. Cosmetic, external skin preparation, and medical instrument
CA2788060C (en) 2010-03-17 2017-07-11 Novaliq Gmbh Pharmaceutical composition for treatment of increased intraocular pressure
JP2013542995A (ja) * 2010-11-18 2013-11-28 ザ プロクター アンド ギャンブル カンパニー Ｎ−アシルアミノ酸化合物及びヘキシルデカノールをベースにした化粧品組成物
US10555887B2 (en) * 2010-12-20 2020-02-11 L'oreal Sterile liquid composition for filling wrinkles
US9296874B2 (en) 2011-04-28 2016-03-29 Ticona Llc Polyacetal compositions and molded products made therefrom
AU2012260787B2 (en) 2011-05-25 2017-02-02 Dermaliq Therapeutics, Inc. Topical pharmaceutical composition based on semifluorinated alkanes
EP2760927A1 (de) 2011-09-29 2014-08-06 Ticona LLC Polymerzusammensetzung zur herstellung von artikeln mit metallischem aussehen
CN113679698B (zh) 2012-09-12 2022-07-26 诺瓦利克有限责任公司 包含半氟化烷烃的混合物的组合物
EP3488847B1 (de) 2012-09-12 2023-11-08 Novaliq GmbH Semifluorierte alkanzusammensetzungen
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
EP2938674A1 (de) 2012-12-27 2015-11-04 Ticona LLC Schlagzähmodifizierte polyoxymethylenzusammensetzung und daraus hergestellte artikel mit stabilität bei exposition gegenüber uv-licht
US9511144B2 (en) 2013-03-14 2016-12-06 The Proctor & Gamble Company Cosmetic compositions and methods providing enhanced penetration of skin care actives
USD750788S1 (en) 2013-11-26 2016-03-01 Acrux Dds Pty Ltd Topical spreading applicator
USD749225S1 (en) 2013-11-26 2016-02-09 Acrux Dds Pty Ltd Topical spreading applicator
EP2944324A1 (de) * 2014-05-13 2015-11-18 LTS LOHMANN Therapie-Systeme AG Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
DE202016008738U1 (de) 2015-09-30 2019-04-09 Novaliq Gmbh Semifluorierte Verbindungen und ihre Zusammensetzungen
US11101463B2 (en) * 2016-03-04 2021-08-24 Showa Denko K.K. Copolymer for binders for nonaqueous battery electrodes, slurry for nonaqueous battery electrodes, nonaqueous battery electrode, and nonaqueous battery
ES2965677T3 (es) 2016-09-23 2024-04-16 Novaliq Gmbh Composiciones oftálmicas que comprenden ciclosporina
CA3076776A1 (en) 2017-09-27 2019-04-04 Novaliq Gmbh Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
US11896559B2 (en) 2017-10-04 2024-02-13 Novaliq Gmbh Opthalmic compositions comprising F6H8
EP3856128B1 (de) 2018-09-27 2023-06-07 Dermaliq Therapeutics, Inc. Topische sonnenschutzmittelformulierung
CN112823020A (zh) 2018-10-12 2021-05-18 诺瓦利克有限责任公司 用于治疗干眼病的眼用组合物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3632547A (en) * 1969-07-02 1972-01-04 Synergistic Ind Inc Textile adhesive and method of use
DE3140156A1 (de) * 1981-10-09 1983-04-28 Beiersdorf Ag, 2000 Hamburg "verspruehbare selbstklebemasse"
JPS6045522B2 (ja) * 1982-12-08 1985-10-09 憲司 中村 化粧用具
US5037656A (en) * 1986-12-04 1991-08-06 Millipore Corporation Porous membrane having hydrophilic and cell growth promotions surface and process
EP0356382B1 (de) * 1988-08-02 1994-02-16 Ciba-Geigy Ag Mehrschichtiges Pflaster
JPH06104116B2 (ja) * 1988-11-29 1994-12-21 三菱化成株式会社 創傷被覆材

Also Published As

Publication number Publication date
JPH04182437A (ja) 1992-06-30
US5455042A (en) 1995-10-03
EP0446636A3 (en) 1991-11-06
EP0446636A2 (de) 1991-09-18
US5254338A (en) 1993-10-19
DE69120107T2 (de) 1997-02-27
EP0446636B1 (de) 1996-06-12
US5344655A (en) 1994-09-06
JP3046346B2 (ja) 2000-05-29

Similar Documents

Publication Publication Date Title
DE69120107D1 (de) Grundlage oder Hilfsstoff zur externen Anwendung sowie diese bzw. diesen enthaltende Mittel zur externen Anwendung an einem menschlichen Wesen oder Tier
DE69109560D1 (de) Fungizide Zusammensetzung zur Behandlung von Saatgut.
DE68907553T2 (de) Make-up-Mittel zur menschlichen Anwendung.
ATE865T1 (de) Hautbehandlungszusammensetzungen, verfahren zu ihrer herstellung und diese zusammensetzungen enthaltender applikator.
DE3579891D1 (de) N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-trifluoromethylpyridin-2-sulfonamide oder salze davon, diese enthaltendes herbizides mittel und verfahren zur herstellung dieser verbindung.
DE68912237T2 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
JPS56142204A (en) Cosmetic composition for hair or skin treatment
DE69100848D1 (de) Hautpflegezusammensetzungen.
DE3870508D1 (de) Zusammensetzung zur behandlung des haares.
DK90089A (da) Hudbehandlingspraeparat
FR2666226B1 (fr) Composition protectrice de la peau.
DE69019345D1 (de) Zusammensetzung zur behandlung von samen.
ATA40579A (de) Fungizides und bakterizides mittel zur be- kaempfung von pflanzenkrankheiten
JPS57183703A (en) Novel composition for cosmetics, sanitation, treatment or agricultural gardening
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
GB2040683B (en) Compositions for treating the hair nd skin which contain alkylene-dithioethers
DE69204658T2 (de) Kosmetische Zusammensetzung zur Haarbehandlung.
PT75856A (pt) Azolyl-penten-derivate verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
DE3480706D1 (de) 5-fluoruracilabkoemmlinge sowie medizinische zusammensetzungen die diese enthalten.
PT76582A (de) 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel
DE69017231D1 (de) Hautpräparat zur äusserlichen anwendung.
DE69002821D1 (de) Zusammensetzung zur haarbehandlung.
PT70247A (pt) Diurethane verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel
LU80683A1 (de) Chloracetanilide,verfahren zur herstellung dieser verbindungen sowie diese enthaltende herbizide mittel
DE68902792D1 (de) Mittel zur kosmetischen oder pharmazeutischen verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition